Language Selector

    Partner Search for the Production of Clinical Lots of Inactivated Bacterial Vaccines

    Published on 12 November 2015
    Author: Marlen Damjanovic, National Contact Point Health, Demographic Change & Wellbeing

    The Spanish University of Navarra is looking for an industrial partner that is willing to participate in a Horizon 2020 Health, Demographic Change and Wellbeing proposal

    The following topic is concerned:

    • SC1-PM-06-2016: Vaccine development for malaria and/or neglected infectious diseases

    The project is devoted to the development of novel vaccines of Shigella. The primary focus is to advance the development of safe, affordable, and effective vaccines for the leading causes of diarrheal and enteric diseases in low- and middle-income countries.

    The industry partner should be a pharma lab accredited for production and inactivation of pathogen bacteria with the purpose of manufacturing vaccines at clinical trial level. It shall be authorised for Biosafety Level 2 (BSL2 or P2) and good manufacturing practices (GMPs) with a capacity of production in the scale of hundreds of litres.

    If you are interested, please contact Marlen Damjanovic